COLUMBIA WANGER ASSET MANAGEMENT LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 199 filers reported holding SEATTLE GENETICS INC in Q2 2013. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
COLUMBIA WANGER ASSET MANAGEMENT LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q4 2017$27,960,000
-15.1%
522,621
-13.6%
0.42%
-14.2%
Q3 2017$32,928,000
+53.7%
605,174
+46.2%
0.49%
+59.2%
Q2 2017$21,420,000
-42.5%
413,994
-30.1%
0.31%
-41.5%
Q1 2017$37,250,000
-7.2%
592,582
-22.1%
0.52%
-7.3%
Q4 2016$40,144,000
+8.8%
760,744
+11.4%
0.56%
+16.8%
Q3 2016$36,887,000
-36.1%
682,974
-52.2%
0.48%
-27.8%
Q2 2016$57,721,000
-6.7%
1,428,393
-19.0%
0.67%
+0.3%
Q1 2016$61,892,000
-14.9%
1,763,796
+8.8%
0.67%
-8.5%
Q4 2015$72,751,000
+2.4%
1,621,001
-12.0%
0.73%
+28.6%
Q3 2015$71,043,000
-37.7%
1,842,396
-21.8%
0.57%
-22.6%
Q2 2015$113,982,000
-5.4%
2,355,005
-30.9%
0.73%
+11.9%
Q1 2015$120,480,000
-16.2%
3,408,200
-23.8%
0.66%
-8.0%
Q4 2014$143,753,000
-25.0%
4,474,100
-13.2%
0.71%
-19.3%
Q3 2014$191,663,000
-24.2%
5,155,000
-22.0%
0.88%
-13.1%
Q2 2014$252,832,000
-16.2%
6,610,000
-0.2%
1.02%
-14.5%
Q1 2014$301,881,000
+12.9%
6,626,000
-1.1%
1.19%
+16.3%
Q4 2013$267,303,000
-19.2%
6,701,000
-11.2%
1.02%
-23.4%
Q3 2013$330,785,000
+29.4%
7,547,000
-7.1%
1.33%
+19.2%
Q2 2013$255,612,0008,125,0001.12%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders